Lotronex REMS’ Verification Process Should Be Electronic, FDA Panel Says
This article was originally published in The Pink Sheet Daily
Executive Summary
Drug Safety and Risk Management Advisory Committee overwhelmingly favors elimination of paper-based sticker system to verify prescriber enrollment and documentation of safe use conditions under Prometheus’ REMS for the irritable bowel syndrome drug.